Healthcare apparel company Figs (NYSE:FIGS) reported Q3 CY2025 results exceeding the market’s revenue expectations , with sales up 8.2% year on year to $151.7 million. Its non-GAAP profit of $0.05 per share was significantly above analysts’ consensus estimates. Is now the time to buy Figs? Find out in our full research report. Figs (FIGS) Q3 CY2025 Highlights: Revenue: $151.7 million vs analyst estimates of $142.5 million (8.2% year-on-year growth, 6.4% beat) Adjusted EPS: $0.05 vs analyst estimates of ...